WeVote
Log In

Bill

Bill

HB 1625

Public Health - Newborn Screening Program - Fees and Core Conditions

2026 Regular Session Introduced by Tiffany Alston and 13 co-sponsors

HB 1625 adjusts newborn screening program fees and expands core screened conditions in Maryland hospitals, now advancing through Finance Committee review.

Hearing 4/01 at 1:00 p.m.
0
WeVote Research Nonpartisan
Bill Summary · HB 1625

Legislative bill overview

HB 1625 modifies Maryland's newborn screening program by adjusting fees charged to hospitals and healthcare facilities and expanding or modifying the list of core conditions screened for in newborns. The bill has passed third reading with strong support (121-14) and is currently in the Finance Committee for budget review before a scheduled hearing on April 1st.

Why is this important

Newborn screening programs are critical public health infrastructure that detect serious genetic, metabolic, and functional disorders in infants before symptoms appear, enabling early treatment that prevents disability or death. Changes to screening fees affect hospital costs and potentially healthcare access, while expanding core conditions directly impacts which diseases are caught early—decisions with lifelong health consequences for affected children and families.

Potential points of contention

  • Cost burden allocation: Whether hospitals, insurers, or the state should bear increased screening fees, which could ultimately affect healthcare costs for families or institutional budgets
  • Scientific justification for expanded conditions: Debate over which additional conditions meet evidence-based criteria for universal newborn screening versus conditions better detected through targeted screening for high-risk populations
  • Implementation and resource capacity: Whether laboratories and healthcare providers have adequate resources, training, and staffing to implement expanded screening without delays or quality issues

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.